Cite
APA Citation
Garralda, E., Geva, R., Ben-Ami, E., Maurice-Dror, C., Calvo, E., LoRusso, P., Türeci, Ö., Niewood, M., Şahin, U., Jure-Kunkel, M., Forssmann, U., Ahmadi, T., & Melero, I. (n.d.). 412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors. Journal for immunotherapy of cancer, 8, A250–A251. http://access.bl.uk/ark:/81055/vdc_100144727243.0x000003